KCTD蛋白质在控制细胞生长方面具有冗余功能
Robert Rizk1, Dominic Devost1, Darlaine Pétrin1
1Department of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir-William-Osler, Room 1303, Montréal, QC H3G 1Y6, Canada.
International journal of molecular sciences
|May 11, 2024
概括
这项研究表明,KCTD2,KCTD5和KCTD17蛋白具有重叠的功能,对细胞存活和增殖至关重要. 它们的联合缺席显著影响细胞生长和基因表达,突出显示了它们在细胞平衡中的关键作用.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 通道四重化域 (KCTD) 蛋白质在结构上是相关的.
- 在KCTD蛋白家族成员中,功能冗余性尚未得到充分理解.
- KCTD蛋白在生长和基因表达等细胞过程中的作用需要进一步研究.
研究的目的:
- 研究KCTD2,KCTD5和KCTD17蛋白的功能冗余性.
- 确定这些KCTD异型逐渐淘汰对细胞生长和基因表达的影响.
- 阐明KCTD蛋白和Gβ1在转录调节中的关系.
主要方法:
- 使用CRISPR/Cas9基因组编辑,在HEK 293细胞中逐渐淘汰了KCTD2,KCTD5和KCTD17.
- 验证的淘汰效率得到了确认.
- 细胞生长和基因表达模式在渐进的KCTD异形淘汰之后进行了评估.
- 在GNB1淘汰和KCTD淘汰细胞之间比较了基因表达特征.
主要成果:
- 逐渐淘汰KCTD异型,特别是三重淘汰,显著影响了细胞生长,表明功能得到保护.
- 基因表达模式显示了与KCTD异形淘汰赛相关的渐进性变化.
- GNB1淘汰改变了其他G蛋白子单元基因的表达,而KCTD淘汰则产生了相反的效果,表明对Gβ1水平的调节.
- 确定了KCTD蛋白和Gβ1之间的独特关系.
结论:
- 这种KCTD蛋白的子家族在维持细胞生存和增殖方面发挥着全球作用.
- KCTD蛋白质参与调节Gβ1水平,影响转录控制.
- 在KCTD2,KCTD5和KCTD17蛋白质中存在功能冗余.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Cell Cycle Control System
2.8K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
2.8K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


